Elegant antibody nanoparticles override immunological tolerance of tumors
Date | 12th, Jul 2019 |
---|---|
Source | EurekAlert - Scientific News Websites |
DESCRIPTION
Scientists from the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.